Skip to content

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Randomized controlled trial · J Health Popul Nutr · 2024. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 38915116

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Kishimoto A, Komiyama M, Wada H et al.
J Health Popul Nutr · 2024

PubMed ID
38915116
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.